Almost 8 years ago, we reported two preterm infants who died of fulminant NEC shortly after being commenced on a commercially available carob bean (locust bean) gum-thickening agent for suspected gastro-esophageal reflux (GER). 3 In their recent systematic review of thickened feed interventions for GER in infants, Horvath et al. 4 discussed the safety aspects of thickeners but may have overlooked our earlier report, because a possible association with NEC was not mentioned as a safety concern. Similarly, the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Gastroenterology, Hepatology, and Nutrition joint clinical practice guideline for pediatric GER discusses treatment of GER using feed thickeners, but without any specific caution for their use in preterm infants. 5 Irrespective of only modest possible benefits from feed thickening in treatment of GER, 4, 5 we have found it perturbing that feed thickeners continue to be recommended for treatment of GER in preterm-born infants, 6 despite the absence of safety data. In preterm infants, GER disease is usually self-limiting and rarely life-threatening in complete contrast to fulminant late-onset NEC. In our opinion, these recent further reports strengthen the likelihood of a causative relationship between the use of feed-thickening agents in infants born preterm and the occurrence of NEC. NEC has now been reported in association with several different thickening agents, including pectin and cellulose, 7 carob-bean gum 3 and xanthan gum. 1 A causative association is biologically plausible, as previously discussed.
1,3 Consequently, we believe that there is presently little justification for the use or recommendation of any feed-thickening agent in infants who were born preterm until reassuring safety data become available in this population.
